Relief of Pain and Inflammation : Non-Steroidal Anti-inflammatory Agents (NSAID)
OBREX1 “Brexin sachets” 191.2 mg/sach (piroxicam Beta-cyclodextrin, eq to piroxicam 20mg)
TFOCU1 “Focus gel” 10 mg/gm; 40 gm/tube
適應症：
OBREX1：骨關節炎、風濕性關節炎、關節黏連性脊椎炎、急性痛風、關節周圍炎、肌纖維炎。肌肉骨骼的不適（腱炎、黏液囊炎、外傷後疼痛）、手術後疼痛、原發性痛經。
TFOCU1：類風濕性關節炎、骨關節炎（關節痛、退化性關節炎）、僵直性脊椎炎、急性肌肉骨骼損傷及急性痛風、肌肉痛外傷後之腫脹及疼痛。
Usual dose:
Ankylosing spondylitis, osteoarthritis, rheumatoid arthritis: 20 mg qd or 10 mg bid.
Gout: 40 mg qd or 20 mg bid.
Contraindication: See Diclofenac Potassium.
Adverse effect:
Common: edema, pruritus, rash, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, heartburn, nausea, vomiting, dizziness, headache.
Serious: Cardiac dysrhythmia, congestive heart failure, hypertension, myocardial infarction, tachyarrhythmia, thrombotic tendency observations, vasculitis, erythema multiforme, scaling eczema, Stevens-Johnson syndrome, gastrointestinal hemorrhage, gastrointestinal perforation, inflammatory disorder of digestive tract, melena, anemia, thrombocytopenic disorder, hepatitis, increased liver function test, jaundice, liver failure, anaphylactoid reaction, cerebrovascular accident, abnormal renal function, interstitial nephritis, nephrotic syndrome, proteinuria, renal failure, asthma, bronchospasm, dyspnea.